EGFR and non-small cell lung carcinoma: They are highly enriched in Asian, nonsmokers, females’ adenocarcinomas, they are associated with poor outcomes, and their frequency has been estimated between 4 and 10% of all documented EGFR alterations in NSCLC [44].